Simple blood test may spot newborns at risk for lung trouble
NCT ID NCT07394322
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether measuring a substance called interleukin-6 (IL-6) in the blood can predict which newborns will develop meconium aspiration syndrome, a serious breathing problem. Researchers tested 120 full-term infants born with meconium-stained amniotic fluid. The goal was to see if IL-6 levels could serve as an early warning sign.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- serum interleukin-6 test
- What this could lead to
- If successful, this could help doctors identify newborns at risk for meconium aspiration syndrome early, allowing for quicker monitoring and care.
- What could go wrong
- This is a small, completed diagnostic study, not a treatment trial. The test may not be accurate enough for routine use, and results need confirmation in larger studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MECONIUM ASPIRATION SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Benha Faculty of Medicine
Banhā, 15312, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.